Piramal Pharma shareholders and shareholding pattern
NSE: PPLPHARMABSE: 543635Pharmaceuticals & BiotechnologySmall Cap
Last close ₹191.07down ₹3.92 (2.01%)BSE ₹190.85
Share price at the NSE close on 23 Oct 2026. Previous close ₹194.99.
52-week range of traded prices to 23 Oct 2026
₹132.30Low, 23 Mar 2026₹231.93High, 8 Sep 2026
- Next results date: the board meets on 27 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹25,438 Cr331st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 Apr 2026
- 3.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 29 Jul 2026
- −3.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹217 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −1.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 29 Jul 2026
- 1.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 28 Apr 2026
- 0.67
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 24,65,51342.5% delivered
Who owns Piramal Pharma, filing by filing
Per cent of the company's shares. Every filing on record, from Dec 2022; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters34.80%
- Foreign institutions13.65%
- Indian institutions14.44%
- GovernmentsNone
- Individuals and others36.71%
- Employee trusts0.40%
Shareholding pattern, per cent
- Promoters
- Foreign institutions
- Indian institutions
- Governments
- Individuals and others
- Employee trusts
| Per cent | Dec 2022Filed 20 Jan | Mar 2023Filed 21 Apr | Jun 2023Filed 18 Jul | Sep 2023Filed 19 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 19 Apr | Jun 2024Filed 19 Jul | Sep 2024Filed 18 Oct | Dec 2024Filed 17 Jan | Mar 2025Filed 21 Apr | Jun 2025Filed 21 Jul | Sep 2025Filed 17 Oct | Dec 2025Filed 20 Jan | Mar 2026Filed 20 Apr | Jun 2026Filed 20 Jul | Sep 2026Filed 21 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.79% | 34.79% | 34.79% | 35.02% | 35.02% | 35.02% | 34.95% | 34.95% | 34.95% | 34.95% | 34.86% | 34.86% | 34.86% | 34.86% | 34.80% | 34.80% | |
| Indian promoters | 34.79% | 34.79% | 34.79% | 35.02% | 35.02% | 35.02% | 34.95% | 34.95% | 34.95% | 34.95% | 34.86% | 34.86% | 34.86% | 34.86% | 34.80% | 34.80% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 64.82% | 64.82% | 64.82% | 64.60% | 64.60% | 64.61% | 64.58% | 64.61% | 64.65% | 64.71% | 64.57% | 64.63% | 64.70% | 64.81% | 64.72% | 64.80% |
| Employee trusts | 0.39% | 0.39% | 0.39% | 0.38% | 0.38% | 0.37% | 0.47% | 0.45% | 0.40% | 0.34% | 0.57% | 0.51% | 0.44% | 0.34% | 0.48% | 0.40% |
| Shares in issue | 1,19,33,18,500 | 1,19,33,18,500 | 1,19,33,18,500 | 1,32,29,48,130 | 1,32,29,48,130 | 1,32,29,48,130 | 1,32,57,48,130 | 1,32,57,48,130 | 1,32,57,48,130 | 1,32,57,48,130 | 1,32,92,48,130 | 1,32,92,48,130 | 1,32,92,48,130 | 1,32,92,48,130 | 1,33,13,48,130 | 1,33,13,48,130 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 23,86,63,700 | 23,86,63,700 | 23,86,63,700 | 23,86,63,700 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Piramal Pharma promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is The Sri Krishna Trust (through its Trustee Mr. Ajay G Piramal and Dr. (Mrs.) Swati A. Piramal), 26.51%. The filing names 50 more members with no shares.Promoter buying and selling
| Holder | ||
|---|---|---|
| The Sri Krishna Trust (through its Trustee Mr. Ajay G Piramal and Dr. (Mrs.) Swati A. Piramal)Indian companies, trusts and others | 26.51% | 35,28,91,420 |
| V3 Designs LLPIndian companies, trusts and others | 3.23% | 4,30,21,826 |
| PRL Realtors LLPIndian companies, trusts and others | 2.99% | 3,97,97,353 |
| Piramal Welfare TrustIndian companies, trusts and others | 0.79% | 1,05,73,898 |
| Semplice Corporate Solutions Private LimitedIndian companies, trusts and others | 0.67% | 89,31,097 |
| The Ajay G Piramal FoundationIndian companies, trusts and others | 0.33% | 43,75,937 |
| Mr. Anand PiramalIndividuals and Hindu undivided families | 0.07% | 8,74,082 |
| Anand Piramal TrustIndian companies, trusts and others | 0.05% | 6,17,884 |
| Nandini Piramal TrustIndian companies, trusts and others | 0.04% | 5,44,325 |
| Mr. Ajay G. PiramalIndividuals and Hindu undivided families | 0.04% | 5,47,326 |
| Mr. Peter DeYoungIndividuals and Hindu undivided families | 0.03% | 4,32,000 |
| Ms. Nandini Ajay PiramalIndividuals and Hindu undivided families | 0.02% | 2,90,418 |
No promoter shares are reported as pledged.
Largest public holders of Piramal Pharma, filing by filing
Per cent, on the same shares as the split above.Mutual funds holding Piramal Pharma
| Holder | Dec 2022Filed 20 Jan | Mar 2023Filed 21 Apr | Jun 2023Filed 18 Jul | Sep 2023Filed 19 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 19 Apr | Jun 2024Filed 19 Jul | Sep 2024Filed 18 Oct | Dec 2024Filed 17 Jan | Mar 2025Filed 21 Apr | Jun 2025Filed 21 Jul | Sep 2025Filed 17 Oct | Dec 2025Filed 20 Jan | Mar 2026Filed 20 Apr | Jun 2026Filed 20 Jul | Sep 2026Filed 21 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ca Alchemy InvestmentsForeign companies | 20.00% | 20.00% | 20.00% | 18.04% | 18.04% | 18.04% | 18.00% | 18.00% | 18.00% | 18.00% | 17.95% | 17.95% | 17.95% | 17.95% | 17.93% | 17.93% |
| East Bridge Capital Master Fund I LtdForeign portfolio investors, category I | 2.17% | 2.17% | 2.17% | 2.17% | 4.71% | 4.35% | 4.35% | 3.27% | 2.65% | 2.61% | 2.23% | 2.00% | 2.00% | 2.00% | 2.00% | 2.00% |
| Indiahold LimitedOther non-institutions | 1.45% | 1.45% | 1.45% | 1.31% | 1.31% | 1.31% | 1.30% | 1.30% | 1.30% | 1.30% | 1.30% | 1.30% | 1.30% | 1.30% | 1.30% | 1.30% |
| Life Insurance Corporation of IndiaInsurance companies | 3.88% | 3.88% | 3.88% | 3.49% | 2.05% | 1.85% | 1.84% | 1.62% | 1.36% | – | – | – | – | – | – | – |
| College Retirement Equities Fund - Stock AccountForeign portfolio investors, category I | 1.08% | 1.27% | 1.59% | 1.58% | 1.20% | – | – | – | – | – | – | – | – | – | – | – |
| East Bridge Capital Master Fund LimitedForeign portfolio investors, category I | 3.46% | 3.41% | 3.21% | 2.74% | – | – | – | – | – | – | – | – | – | – | – | – |
| Caisse De Depot Et Placement Du QuebecForeign portfolio investors, category I | 5.65% | 5.53% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.